Select Page

All News

MeCRU Research Unit Officially launched as Paediatric COVID-19 VACCINE Trial Site

MeCRU Research Unit (MeCRU), at SMU has been officially launched as the research site for Phase III Paediatric COVID-19 Vaccine study conducted by the Numolux Group and Sinovac on 10 September 2021. The very first child and the second one had the honor to receive their jabs which kick started the study.

Related News

SMU celebrates first female Mathematics PhD graduate

SMU celebrates first female Mathematics PhD graduate

Dr Rose Maluleka has made history at Sefako Makgatho Health Sciences University (SMU) by becoming the first female PhD graduate in the Department of Mathematics and Applied Mathematics, marking a significant milestone for the university and an important achievement...

SMU researcher earns PhD in entrepreneurship

SMU researcher earns PhD in entrepreneurship

Sefako Makgatho Health Sciences University (SMU) is celebrating the academic achievement of Dr Benjamin Tlhale Ntshabele, an Institutional Researcher in the Institutional Planning and Quality Assurance (IPQA) Department, who recently obtained a Doctor of Philosophy...

SMU scholar advances interdisciplinary health research

SMU scholar advances interdisciplinary health research

The graduation of Dr Daniële Kristen, the third PhD graduate from the Anatomy and Histology Department at Sefako Makgatho Health Sciences University (SMU), marks an important milestone in postgraduate education, teaching excellence and interdisciplinary research...